Erik Emerson is the founder of Apimeds Pharmaceuticals. Apimeds Pharmaceuticals has raised $100M in total funding. Latest round: Growth.
Erik Emerson served as the Chief Executive Officer at Apimeds Pharmaceuticals US, Inc., a clinical-stage biopharmaceutical company. He was removed from the board of directors of Apimeds Pharmaceuticals and is currently the CEO of Lokahi Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library